VSTM2A (V-set and transmembrane domain containing 2A) Blocking Peptide (the middle region of protein) (100ug)

This is a synthetic peptide designed for use in combination with anti-VSTM2A antibody (Catalogue #: ARP55814_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

Prices direct from Aviva Systems Biology Incorporated

Quick response times

Exclusive Absave savings/discounts

SPECIFICATIONS

Size

100 ug

Format

Lyophilized powder

Presku

AAP55814

Target

The specific function of this protein remains unknown.This pseudogene is a member of the cytochrome P450 gene superfamily. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. It is possible that, in rare cases, a combination of two SNPs in this gene may result in an open reading frame encoding a functional enzyme which metabolizes codeine to morphine. This locus is part of a cluster of cytochrome P450 genes on chromosome 22q13.1. PRIMARYREFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-291 BX247885.11 23767-24057 c 292-463 BX247885.11 22893-23064 c 464-616 BX247885.11 22211-22363 c 617-777 BX247885.11 21962-22122 c 778-954 BX247885.11 21360-21536 c 955-1096 BX247885.11 21026-21167 c 1097-1284 BX247885.11 20644-20831 c 1285-1426 BX247885.11 20048-20189 c 1427-1680 BX247885.11 19696-19949 c

Weight

26kDa

Gene Id

222008

Alternative Names

MGC33530; VSTM2